SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris

Detalles Bibliográficos
Autores principales: Fenizia, Claudio, Moltrasio, Chiara, Ottobrini, Luisa, Utyro, Olga, Genovese, Giovanni, Vanetti, Claudia, Trabattoni, Daria, Marzano, Angelo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883068/
https://www.ncbi.nlm.nih.gov/pubmed/36716924
http://dx.doi.org/10.1016/j.jid.2022.12.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883068/
https://www.ncbi.nlm.nih.gov/pubmed/36716924
http://dx.doi.org/10.1016/j.jid.2022.12.023

Ejemplares similares